Prilosec OTC Product Monograph. 1. Introduction. Here are all of the details you need to better understand Prilosec OTC before recommending it to patients. Indication. Yosprala ® is a prescription medicine used: in people who have had heart problems or strokes caused by blood clots, to help reduce their risk of further heart problems or strokes, and 20 mg PO once daily for 4 to 8 weeks. If a patient does not respond to 8 weeks of treatment, an additional 4 weeks of treatment may be given. If there is recurrence of erosive esophagitis, additional 4 to 8 week courses of omeprazole may be considered. Learn about Coumadin (Warfarin Sodium) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. More in FDA Adverse Event Reporting System (FAERS) FDA Adverse Event Reporting System (FAERS): Latest Quarterly Data Files FDA Adverse Event Reporting System (FAERS) Public Dashboard Potential. Original New Drug Approvals (NDAs and BLAs) by Month All applications approved for the first time during the selected month. Includes New Molecular Entities (NMEs) and new biologics. Omeprazole and Sodium Bicarbonate Capsule official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. Gastroesophageal Reflux Disease (GERD) Table 1: Recommended Dosage Schedule of Esomeprazole Strontium Delayed-Release Capsules. Indication Dose Frequency Recommended Pediatric Dosage Regimen by Indication. Table 2 shows the recommended dosage of Omeprazole Delayed-Release Capsules in pediatric patients by indication. ZEGERID (omeprazole/sodium bicarbonate) Immediate-release Capsules. DESCRIPTION. ZEGERID® (omeprazole/sodium bicarbonate) is a combination of omeprazole, a proton-pump inhibitor, and sodium bicarbonate, an antacid.